AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA

Not yet recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 30, 2025

Conditions
Cardiovascular DiseasesHypertrophic Cardiomyopathy (HCM)Dilated Cardiomyopathy (DCM)Restrictive CardiomyopathyAmyloid CardiomyopathyIschemic CardiomyopathyArrhythmogenic Right Ventricular CardiomyopathyMyocarditisCardiomyopathies
Interventions
DIAGNOSTIC_TEST

CCTAI model

Using a derivative sub-cohort, the investigators aim to first develop an CCTA-based AI-assisted (CCTAI) screening model to distinguish patients with cardiac abnormalities from those normal controls. Second, the investigators target at developing a CCTAI diagnostic model with multi-classification output of cardiomyopathy diagnosis. Both models will be tested in internal validation cohort and external validation cohort.

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER